-
Electronic (PDF)
-
Site License
-
Enterprisewide
InSite Vision Incorporated (INSV) - Financial and Strategic SWOT Analysis Review
GlobalData, March 2013, Pages: 43
Summary
InSite Vision Incorporated (InSite) is an ophthalmic product development company. It develops and markets products for the treatment of inflammation and pain related to eye diseases. Its products are developed using DuraSite, the company's proprietary drug delivery technology. The company's marketed product portfolio comprises of AzaSite and Besivance and product under development include DexaSite, AzaSite Plus, BromSite, ISV-101, AzaSite Xtra, ISV-102, ISV-620 and ISV-215. These drugs are administered for the treatment of glaucoma, post-operative ocular inflammation, blepharitis, bacterial conjunctivitis, dry eye diseases and ocular infections.
InSite Vision Incorporated Key Recent Developments
Mar 05, 2013: InSite Vision Reports Revenue Of $21.6m In 2012
Nov 08, 2012: InSite Vision Reports Revenue Of $12.1m In Q3 2012
Sep 05, 2012: InSite Vision Introduces DuraSite 2 Ophthalmic Drug Delivery System
Jul 31, 2012: InSite Vision Reports Revenue Of $1.8m In Q2 2012
May 01, 2012: InSite Vision Reports Revenue Of $2.3m In Q1 2012
This comprehensive SWOT profile of InSite Vision Incorporated provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
List of Tables
List of Figures
Section 1 - About the Company
InSite Vision Incorporated - Key Facts
InSite Vision Incorporated - Key Employees
InSite Vision Incorporated - Key Employee Biographies
InSite Vision Incorporated - Major Products and Services
InSite Vision Incorporated - Pharmaceutical Pipeline Products Data
InSite Vision Incorporated, Pipeline Products by Therapy Area
InSite Vision Incorporated, Pipeline Products by Development Phase
InSite Vision Incorporated - History
InSite Vision Incorporated - Company Statement
InSite Vision Incorporated - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
InSite Vision Incorporated - Business Description
InSite Vision Incorporated - Corporate Strategy
InSite Vision Incorporated - SWOT Analysis
SWOT Analysis - Overview
InSite Vision Incorporated - Strengths
Strength - Proprietary DuraSite Technology
Strength - Strong Patent Portfolio
Strength - Focused Research and Development
InSite Vision Incorporated - Weaknesses
Weakness - Lack of Manufacturing and Marketing Capabilities
InSite Vision Incorporated - Opportunities
Opportunity - Strategic Alliances and Agreements
Opportunity - Ocular Inflammation and Pain Market
Opportunity - Changing Demographics
InSite Vision Incorporated - Threats
Threat - Tightening of FDA’s Regulatory Oversight
Threat - Intense competition
Threat - Uncertainties in R&D
InSite Vision Incorporated - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
InSite Vision Incorporated, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
InSite Vision Incorporated, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
InSite Vision Incorporated, Medical Equipment, Deals By Year, 2007 to YTD 2013
InSite Vision Incorporated, Medical Equipment, Deals By Type, 2007 to YTD 2013
InSite Vision Incorporated, Recent Deals Summary
Section 5 – Company’s Recent Developments
InSite Vision Incorporated, Recent Developments
Mar 05, 2013: InSite Vision Reports Revenue Of $21.6m In 2012
Nov 08, 2012: InSite Vision Reports Revenue Of $12.1m In Q3 2012
Sep 05, 2012: InSite Vision Introduces DuraSite 2 Ophthalmic Drug Delivery System
Jul 31, 2012: InSite Vision Reports Revenue Of $1.8m In Q2 2012
May 01, 2012: InSite Vision Reports Revenue Of $2.3m In Q1 2012
Feb 28, 2012: InSite Vision Reports Revenue Of $15.9m In 2011
Jan 09, 2012: InSite Vision Receives Broad Patent Approval In Japan
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer
List of Tables
InSite Vision Incorporated, Key Facts
InSite Vision Incorporated, Key Employees
InSite Vision Incorporated, Key Employee Biographies
InSite Vision Incorporated, Major Products and Services
InSite Vision Incorporated, Number of Pipeline Products by Therapy Area
InSite Vision Incorporated, Number of Pipeline Products by Development Stage
InSite Vision Incorporated, Pipeline Products By Therapy Area and Development Phase
InSite Vision Incorporated, History
InSite Vision Incorporated, Subsidiaries
InSite Vision Incorporated, Key Competitors
InSite Vision Incorporated, Ratios based on current share price
InSite Vision Incorporated, Annual Ratios
InSite Vision Incorporated, Interim Ratios
InSite Vision Incorporated, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
InSite Vision Incorporated, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
InSite Vision Incorporated, Medical Equipment, Deals By Year, 2007 to YTD 2013
InSite Vision Incorporated, Medical Equipment, Deals By Type, 2007 to YTD 2013
InSite Vision Incorporated, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
InSite Vision Incorporated, Pipeline Products by Therapy Area
InSite Vision Incorporated, Pipeline Products by Development Phase
InSite Vision Incorporated, Performance Chart (2007 - 2011)
InSite Vision Incorporated, Ratio Charts
InSite Vision Incorporated, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
InSite Vision Incorporated, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013
InSite Vision Incorporated, Medical Equipment, Deals By Year, 2007 to YTD 2013
InSite Vision Incorporated, Medical Equipment, Deals by Type, 2007 to YTD 2013
Pfizer Inc.
Johnson & Johnson
Merck & Co., Inc.
Novartis Ophthalmic
Alcon Laboratories, Inc.
Allergan, Inc.
Bausch & Lomb Incorporated
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
